DC Circuit - The FindLaw DC Circuit Court of Appeals Opinion Summaries Blog

Recently in Intellectual Property Law Category

For listeners of streaming radio services, like Pandora, the recent decision over the licensing rates for those service providers may not have much of an impact.

But, for some of the copyright holders, the decision in SoundExchange v. Copyright Royalty Board, is bad news. Basically, the appellate court rejected the challengers' argument that the Board failed to adequately represent their rights when negotiating the rates for the 2016 to 2020 time period.

Court: Everybody Gets 'La Michoanaca'

In Mexico, "La Michoacana" refers to a Michoacan girl holding a specialty ice cream cone in advertisements.

But in Paleteria La Michoacana Inc. v. Productos Lacteos Tocumbo, a federal appeals court said the reference is so commonplace it cannot be claimed by one business over another in the United States. The decision settled a decades-long issue in an international trademark dispute.

Unlike the "paleta" ice cream, however, it was a bittersweet decision. The good news is that you don't have to speak Spanish to understand what happened.

In an opinion out of the D.C. Circuit Court of Appeals, the massive pharma company Boehringer seems to have squeezed out a narrow victory in a rather large discovery dispute over attorney-client privileged communications between corporate employees and corporate attorneys.

And while the court upheld the district court's ruling that attorney-client privilege applied to the communications between employee and attorney, the underlying facts of the communication could nevertheless be fair game.

While using your smartphone, have you ever sent a text message to or called someone who didn't you give you their number, or explicitly consent for you to call or text? If you have, there's good and bad news.

First the bad news: Apparently, you broke the current FCC commissioners understanding of the TCPA (Telephone Consumer Protection Act) by texting/calling without consent. Now the good news: The D.C. Circuit just killed the FCC's interpretation of the rule that could have, theoretically (in some magical land), been used to allow individuals to sue each other over, and this is according the majority opinion here, unexpected social gathering invitations.

Fine Upheld Against Polish Broadcaster for U.S. Copyright Violations

Court observers saw Spanski Enterprises v. Polska as a copyright stand-off.

In one corner of Poland, Telewizja Polska was broadcasting television episodes on the internet for on-demand users. In another corner of New York City, lawyers discovered by downloading the episodes that the programs violated U.S. copyright law.

The controversy made it to the U.S. Circuit Court of Appeals for the District of Columbia, where the judges resolved it. TV Polska owes the copyright holders more than $3 million.

Big Telecom Urges D.C. en Banc Review of Net Neutrality Ruling

Several weeks have passed since the D.C. Circuit ruled that the FCC possessed the power to reclassify broadband companies as telecom common carriers, thereby subjecting them to regulatory authority. Well, some of the bigger names in the industry have already decided to fight back.

It was the kind of petition we just knew was in the works. After all, the reclassification stands to shake up potentially billions of dollars in investment by interested parties. What's a little extra cost for petitioning?

Congress's Democratic leaders want the D.C. Circuit to know they are anything but neutral when it comes to net neutrality. More than two dozen congressional senators and representatives have signed on to an amicus brief supporting the FCC's right to regulate Internet service providers as "common carriers."

The amicus brief puts the Congress members, lead by Senator Edward Markey and Representative Anna Eshoo, against the telecom industry, which has sued to prevent the FCC's new net neutrality rules.

American music would be much worse without college radio. College radio stations helped bring us The Pixies and music-snob mags like CMJ. Your local college radio station is one of the few places willing to let kids spin avant-garde African pop for an hour every week.

But college radio is much less actual radio, these days. Many college radio stations have taken to streaming their music live over the Internet, to potentially much larger audiences. That means more royalty fees, fees the D.C. Circuit just upheld this Tuesday.

TSA Was Arbitrary and Capricious in Dismissing X-Ray Bin Company

As you're waiting in line at the airport to get your full body scan, or have your stuff rifled through, you might peer over at the stack of bins, into which you're hastily stuffing your laptop and shoes, and notice that there are ads in them. Since 2007, the TSA has offset the cost of security checkpoints by selling ad space in the bottom of its X-ray bins.

And it's these bins and their ads that are the basis of a lawsuit decided by the D.C. Circuit Court on Tuesday, one that deals with First Amendment rights, patent infringement -- and murder! (Admittedly, I made that last one up to make the story sound more enticing.)

FDA Lacked Inherent Authority to Reclassify Medical Device: D.C. Cir.

When does a federal agency have "inherent authority"? Not in this case, according to the D.C. Circuit Court in Ivy Sports Medicine v. Burwell.

ReGen Biologics made a device called a Collagen Scaffold for use in knee surgery. ReGen began the process of obtaining FDA approval for the device in 2004. In 2006, several members of Congress from New Jersey, where ReGen is based, expressed concern about the review process. In 2008, the FDA ultimately classified the Collagen Scaffold as a Class II device, which requires less regulation.

But months after getting the approval, a Wall Street Journal article alleged "political pressure" in the Collagen Scaffold approval process. Members of Congress expressed umbrage (no doubt in the most public ways possible) and the FDA investigated, finding that ReGen was a little too close to FDA officials, who didn't follow standard procedures when approving the Collagen Scaffold. The FDA summarily reclassified the device as a Class III device, which had the practical effect of making it unmarketable unless ReGen applied all over again.